2 articles
Health care-associated bloodstream infections represent a major public health concern, significantly impacting morbidity, mortality, and the overall cost of pediatric medical care.
A literature review was conducted based on systematic searches in PubMed, SCOPUS, and Web of Science, following PRISMA guidelines.
The incidence of healthcare-associated bloodstream infections ranges from 2 to 25 cases per 1,000 central venous catheter days, with higher rates reported in pediatric and neonatal intensive care units, where patients are frequently exposed to risk factors such as central venous catheter use, mechanical ventilation, and immunosuppression. Pediatric patients with health care-associated bloodstream infections experience significantly longer hospital stays compared to those without infection (25 vs. 7 days, P < 0.0001). In pediatric intensive care units, the average length of hospital stay due to these infections varies between 11.40 and 21.10 days, while in neonatal intensive care units, it ranges from 4 to 27.80 days. Mortality associated with these infections among children varies between 15% and 50%, depending on the severity of infection and underlying comorbidities. Additionally, health care-associated bloodstream infections lead to increased use of medical resources and generate substantial additional costs for the healthcare system-costs that are, in fact, largely preventable.
Evidence-based strategies, such as strict hand hygiene and standardized protocols for medical device use, can significantly reduce the incidence of these infections.
Hemophilia is a genetic disorder characterized by impaired blood coagulation, leading to increased bleeding risk. The severity of hemophilia varies significantly among individuals, influenced by genetic factors, family inheritance patterns, and the occurrence of complications such as hemarthrosis. Understanding these interrelationships is crucial for developing tailored management strategies for affected children. The purpose of this article is to explore the correlations between clinical severity and various factors, including modes of inheritance, hemarthrosis incidence, types of genetic mutations, and inhibitor presence in pediatric patients with hemophilia. By elucidating these relationships, the study aims to contribute to improved diagnostic and therapeutic approaches in this population.
This retrospective analysis included 90 pediatric patients diagnosed with hemophilia. Clinical data regarding disease severity, inheritance patterns, hemarthrosis incidents, genetic mutation types, and inhibitor levels were collected and analyzed statistically to identify significant associations.
The analysis revealed a strong correlation between familial inheritance patterns and disease severity, with moderate forms predominating in known inheritance cases. Hemarthrosis was most prevalent in severe cases, particularly affecting the knee and elbow joints. The study also found significant associations between genetic mutations, especially missense mutations, and the severity of hemophilia. Furthermore, elevated inhibitor levels were exclusively observed in severe forms of the disease.
The findings highlight the intricate relationships between clinical characteristics and hemophilia severity, emphasizing the necessity for individualized treatment strategies. Understanding these dynamics can facilitate better management of hemophilia in pediatric patients, ultimately improving their quality of life.